Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Gilead Sciences
About
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
- 10001 - max
Highlights
Details
- Industries
- Biopharma,Biotechnology,Health Care,Manufacturing,Pharmaceutical
- Founded date
- Jun 22, 1987
- Number Of Employee
- 10001 - max
- Operating Status
- Active
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases.Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Feb 1, 2021
Arcus Biosciences
|
Post-IPO Equity | $220.35M | Biotechnology | Yes |
|
May 28, 2020
Arcus Biosciences
|
Post-IPO Equity | $200M | Biotechnology | Yes |
|
Jul 14, 2019
Galapagos
|
Post-IPO Equity | $5.10B | Biopharma | Yes |
Acquisition
Gilead Sciences has acquired 1 organizations. Their most recent acquisition was Kite Pharma on Aug 28, 2017. They acquired Kite Pharma for $11.90B.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Aug 28, 2017
Kite Pharma
|
Biotechnology | acquisition | $ 11.90B | Detail |
